Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Baker

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Leukemia|April 30, 2022
Increased expression of RUNX3 inhibits normal human myeloid developmentAna Catarina Menezes, Rachel Jones, Alina Shrestha, et al.
Annals of Vascular Surgery|August 17, 2018
Quantification of Daily Physical Activity and Sedentary Behavior of Claudicating PatientsHernan Hernandez, Sara A Myers, Molly Schieber, et al.
British Journal of Haematology|September 30, 2020
Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivoNamrata Rastogi, Sarah Baker, Stephen Man, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2018
Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastomaSunita Ghosh, Sarah Baker, Douglas Guedes de Castro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 17, 2022
BSACI guideline for the diagnosis and management of pollen food syndrome in the UKIsabel J Skypala, Hannah Hunter, Mamidipudi Thirumala Krishna, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2018
Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease RecurrenceKaren P Chu, Sarah Baker, Julianna Zenke, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2026
Treatment With Stereotactic Ablative Radiotherapy for patients with Up to 5 Oligometastatic cancer lesions: Long-Term Outcomes of the Nonrandomized Population-Based Phase 2 SABR-5 Clinical TrialCurtis Leclerc, Sarah Baker, Will Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 TrialSarah Baker, Benjamin Mou, Will Jiang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 1, 2025
Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT)Mich Erlewyn-Lajeunesse, Luciano Perfetti Villa, Shifa Shaikh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapyEmily O'Reilly, Eshawn Johal, Haley Clark, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Leukemia|April 30, 2022
Increased expression of RUNX3 inhibits normal human myeloid developmentAna Catarina Menezes, Rachel Jones, Alina Shrestha, et al.
Annals of Vascular Surgery|August 17, 2018
Quantification of Daily Physical Activity and Sedentary Behavior of Claudicating PatientsHernan Hernandez, Sara A Myers, Molly Schieber, et al.
British Journal of Haematology|September 30, 2020
Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivoNamrata Rastogi, Sarah Baker, Stephen Man, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2018
Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastomaSunita Ghosh, Sarah Baker, Douglas Guedes de Castro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 17, 2022
BSACI guideline for the diagnosis and management of pollen food syndrome in the UKIsabel J Skypala, Hannah Hunter, Mamidipudi Thirumala Krishna, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2018
Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease RecurrenceKaren P Chu, Sarah Baker, Julianna Zenke, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2026
Treatment With Stereotactic Ablative Radiotherapy for patients with Up to 5 Oligometastatic cancer lesions: Long-Term Outcomes of the Nonrandomized Population-Based Phase 2 SABR-5 Clinical TrialCurtis Leclerc, Sarah Baker, Will Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 TrialSarah Baker, Benjamin Mou, Will Jiang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 1, 2025
Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT)Mich Erlewyn-Lajeunesse, Luciano Perfetti Villa, Shifa Shaikh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2025
Impact of clinical target volume utilization on outcomes in patients with non-spine bone oligometastases treated with stereotactic ablative radiation therapyEmily O'Reilly, Eshawn Johal, Haley Clark, et al.
Pageof 13